Stem Cell Therapy for Sequestration of Traumatic Brain Injury-Induced Inflammation

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Traumatic brain injury (TBI) is one of the leading causes of long-term neurological disabilities in the world. TBI is a signature disease for soldiers and veterans, but also affects civilians, including adults and children. Following TBI, the brain resident and immune cells turn into a “reactive” state, characterized by the production of inflammatory mediators that contribute to the development of cognitive deficits. Other injuries to the brain, including radiation exposure, may trigger TBI-like pathology, characterized by inflammation. Currently there are no treatments to prevent or reverse the deleterious consequences of brain trauma. The recognition that TBI predisposes stem cell alterations suggests that stem cell-based therapies stand as a potential treatment for TBI. Here, we discuss the inflamed brain after TBI and radiation injury. We further review the status of stem cells in the inflamed brain and the applications of cell therapy in sequestering inflammation in TBI.

Cite

CITATION STYLE

APA

Borlongan, M. C., & Rosi, S. (2022, September 1). Stem Cell Therapy for Sequestration of Traumatic Brain Injury-Induced Inflammation. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms231810286

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free